Clinical Significance of Circulating Tumor Cells in in-operable Lung Cancer
Not Applicable
- Conditions
- ung cancer
- Registration Number
- JPRN-UMIN000005037
- Lead Sponsor
- iigata Lung Cancer Treatment Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1.Double cancer 2.sevior complication of major organ
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To elucidate the rlationship between CTC and OS(over all survival).
- Secondary Outcome Measures
Name Time Method To elucidate the rlationship between CTC and DFS (disease free survival), tumor response and recurrence site.